HIV/HPV RDTs
HIV, HPV
Key Facts
About Access Bio
Access Bio is a commercial-stage diagnostics company with a 20+ year history focused on combating infectious diseases in global health settings. It successfully leveraged its IVD platform to become a significant player in the COVID-19 response, securing multiple FDA Emergency Use Authorizations (EUAs) for antigen, antibody, and molecular tests under its CareStart™ brand. While COVID-19 products were a major recent focus, the company's core expertise and legacy are in malaria and other serious tropical diseases, supplying tests to organizations in low-resource regions. The company appears to have a public listing via Korean Depository Receipts (KDRs), indicating a complex corporate structure with operations in the US and South Korea.
View full company profile